Prof. Saleh A. Naser

University of Central Florida, USA

Email: saleh.naser@ucf.edu

Qualifications

1993  Ph.D., New Mexico State University, USA

Publications (selected)

1. Naser, S.A. D. Schwartz I. Shafran. 2000. Isolation of Mycobacterium avium subsp paratuberculosis from Breast Milk of Crohn’s Disease Patients. American Journal of Gastroenterology. 95(4):1094-1095.
2. Shafran, I., Kuqler, L., El-Zaatari, F.A., Naser, S.A., Sandoval, J. 2002. Open Clinical Trial  of Rifabutin and Clarithromycin in therapy in Crohn’s Disease. Digestive and Liver Disease Journal. 34(1):22-28.
3. Naser SA, Ghobrial G, Romero C, Valentine JF. 2004. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet. 2004 Sep 18;364(9439):1039-44.
4. Kaittanis C, Naser SA, Perez JM. One-step, nanoparticle-mediated bacterial detection with magnetic relaxation. Nano Lett. 2007 Feb;7(2):380-3.
5. Chamberlin W, Ghobrial G, Chehtane M, Naser SA. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis. Am J Gastroenterol. 2007 Mar;102(3):689-91.
6. Beckler DR, Elwasila S, Ghobrial G, Valentine JF, Naser SA. Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World J Gastroenterol. 2008 May 7;14(17):2723-30.
7. Naser SA, Romero C, Urbina P, Naser N, Valentine J. Cellular infiltration and cytokine expression correlate with fistulizing state in Crohn's disease. Clin Vaccine Immunol. 2011 Sep;18(9):1416-9.